Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas
Proliferation markers are widely used in general surgical pathology and also in pituitary pathology. They should help for differing aggressive or rapidly growing tumors from those with slower growth, as cellular atypia is not helpful for identifying aggressive adenomas of the pituitary. Only the num...
Gespeichert in:
| Veröffentlicht in: | Frontiers of hormone research 2004-01, Vol.32, p.110-126 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 126 |
|---|---|
| container_issue | |
| container_start_page | 110 |
| container_title | Frontiers of hormone research |
| container_volume | 32 |
| creator | Saeger, W. |
| description | Proliferation markers are widely used in general surgical pathology and also in pituitary pathology. They should help for differing aggressive or rapidly growing tumors from those with slower growth, as cellular atypia is not helpful for identifying aggressive adenomas of the pituitary. Only the number of mitoses is important for prognosis. A lot of markers can be used: antibodies for cyclins A, B, D and E, for proliferating cell nuclear antigen, Ki-67/Mib-1, antibodies for the inhibitory proteins p16, p27, p53, and for DNA topoisomerase IIalpha. A marker for apoptosis and its inhibitors may be also important. From our experiences, Mib-1 is the most reliable marker. The recommendation of this marker in the WHO classification of pituitary adenomas is fully justified. |
| doi_str_mv | 10.1159/000079040 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_ebookcentralchapters_3016282_10_120</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EBC3016282_10_120</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-72561c9fc2e7d6d651e4882a3b06f63a38e8cb584833d16186c1d95cc72b79053</originalsourceid><addsrcrecordid>eNqFkT9T3DAQxUUCyV2AIl-AcZFJZ7IrWf9K5oYkzJCBIqk1srwGcT77kHwF3x4NB00attlif29n31vGviKcI0r7A0ppCw0csFOrjRBoAEEb_YEtUSleC634x_3MgJRaNyAO2RIEYC1Ai09sITUXUphmwb7k_AAgrQX1mS1QcoOi4Ut2eZumIfaU_Bynsfrj05pSrvzYVSsahmr1FAaqrsb72MZ5KpM4Vrdx3sXZp6fqoqNx2vh8wo56P2Q6fe3H7N_Py7-r3_X1za-r1cV1Hcqxc625VBhsHzjpTnVKIjXGcC9aUL0SXhgyoZWmKW47VGhUwM7KEDRvSxRSHLPv-73bND3uKM9uE3Mod_qRpl12SmnJG6vfBTlyBCtsAc9ewV27oc5tU9wUZ-4toQKI_zZRO03rQOOc_BDu_XYugbkSuuKGOwSHHIqq2qvWPt1R2mtyphQpu5evFuTbO4jbdr14Bskelgw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>EBC3016282_10_120</pqid></control><display><type>article</type><title>Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas</title><source>Karger eBooks Collection Archiv (DFG Nationallizenzen)</source><source>MEDLINE</source><source>Karger Book Series</source><creator>Saeger, W.</creator><contributor>Kontogeorgos G ; Kovacs K ; Kovacs, K ; Kontogeorgos, G</contributor><creatorcontrib>Saeger, W. ; Kontogeorgos G ; Kovacs K ; Kovacs, K ; Kontogeorgos, G</creatorcontrib><description>Proliferation markers are widely used in general surgical pathology and also in pituitary pathology. They should help for differing aggressive or rapidly growing tumors from those with slower growth, as cellular atypia is not helpful for identifying aggressive adenomas of the pituitary. Only the number of mitoses is important for prognosis. A lot of markers can be used: antibodies for cyclins A, B, D and E, for proliferating cell nuclear antigen, Ki-67/Mib-1, antibodies for the inhibitory proteins p16, p27, p53, and for DNA topoisomerase IIalpha. A marker for apoptosis and its inhibitors may be also important. From our experiences, Mib-1 is the most reliable marker. The recommendation of this marker in the WHO classification of pituitary adenomas is fully justified.</description><identifier>ISSN: 0301-3073</identifier><identifier>ISBN: 9783805577403</identifier><identifier>ISBN: 3805577400</identifier><identifier>EISSN: 1662-3762</identifier><identifier>EISBN: 9783318010787</identifier><identifier>EISBN: 3318010782</identifier><identifier>DOI: 10.1159/000079040</identifier><identifier>OCLC: 57235384</identifier><identifier>PMID: 15281342</identifier><identifier>LCCallNum: RC280.P5 M656 2004</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Adenoma - metabolism ; Adenoma - pathology ; Biomarkers, Tumor - metabolism ; Cell Cycle ; Cell Division ; Chapter ; Humans ; Pituitary Neoplasms - metabolism ; Pituitary Neoplasms - pathology</subject><ispartof>Frontiers of hormone research, 2004-01, Vol.32, p.110-126</ispartof><rights>2004 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-72561c9fc2e7d6d651e4882a3b06f63a38e8cb584833d16186c1d95cc72b79053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttps://ebookcentral.proquest.com/covers/3016282-l.jpg</thumbnail><link.rule.ids>779,780,784,793,26081,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15281342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kontogeorgos G</contributor><contributor>Kovacs K</contributor><contributor>Kovacs, K</contributor><contributor>Kontogeorgos, G</contributor><creatorcontrib>Saeger, W.</creatorcontrib><title>Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas</title><title>Frontiers of hormone research</title><addtitle>Front Horm Res</addtitle><description>Proliferation markers are widely used in general surgical pathology and also in pituitary pathology. They should help for differing aggressive or rapidly growing tumors from those with slower growth, as cellular atypia is not helpful for identifying aggressive adenomas of the pituitary. Only the number of mitoses is important for prognosis. A lot of markers can be used: antibodies for cyclins A, B, D and E, for proliferating cell nuclear antigen, Ki-67/Mib-1, antibodies for the inhibitory proteins p16, p27, p53, and for DNA topoisomerase IIalpha. A marker for apoptosis and its inhibitors may be also important. From our experiences, Mib-1 is the most reliable marker. The recommendation of this marker in the WHO classification of pituitary adenomas is fully justified.</description><subject>Adenoma - metabolism</subject><subject>Adenoma - pathology</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Cycle</subject><subject>Cell Division</subject><subject>Chapter</subject><subject>Humans</subject><subject>Pituitary Neoplasms - metabolism</subject><subject>Pituitary Neoplasms - pathology</subject><issn>0301-3073</issn><issn>1662-3762</issn><isbn>9783805577403</isbn><isbn>3805577400</isbn><isbn>9783318010787</isbn><isbn>3318010782</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT9T3DAQxUUCyV2AIl-AcZFJZ7IrWf9K5oYkzJCBIqk1srwGcT77kHwF3x4NB00attlif29n31vGviKcI0r7A0ppCw0csFOrjRBoAEEb_YEtUSleC634x_3MgJRaNyAO2RIEYC1Ai09sITUXUphmwb7k_AAgrQX1mS1QcoOi4Ut2eZumIfaU_Bynsfrj05pSrvzYVSsahmr1FAaqrsb72MZ5KpM4Vrdx3sXZp6fqoqNx2vh8wo56P2Q6fe3H7N_Py7-r3_X1za-r1cV1Hcqxc625VBhsHzjpTnVKIjXGcC9aUL0SXhgyoZWmKW47VGhUwM7KEDRvSxRSHLPv-73bND3uKM9uE3Mod_qRpl12SmnJG6vfBTlyBCtsAc9ewV27oc5tU9wUZ-4toQKI_zZRO03rQOOc_BDu_XYugbkSuuKGOwSHHIqq2qvWPt1R2mtyphQpu5evFuTbO4jbdr14Bskelgw</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Saeger, W.</creator><general>S. Karger AG</general><scope>FFUUA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20040101</creationdate><title>Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas</title><author>Saeger, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-72561c9fc2e7d6d651e4882a3b06f63a38e8cb584833d16186c1d95cc72b79053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenoma - metabolism</topic><topic>Adenoma - pathology</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Cycle</topic><topic>Cell Division</topic><topic>Chapter</topic><topic>Humans</topic><topic>Pituitary Neoplasms - metabolism</topic><topic>Pituitary Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saeger, W.</creatorcontrib><collection>ProQuest Ebook Central - Book Chapters - Demo use only</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Frontiers of hormone research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saeger, W.</au><au>Kontogeorgos G</au><au>Kovacs K</au><au>Kovacs, K</au><au>Kontogeorgos, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas</atitle><jtitle>Frontiers of hormone research</jtitle><addtitle>Front Horm Res</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>32</volume><spage>110</spage><epage>126</epage><pages>110-126</pages><issn>0301-3073</issn><eissn>1662-3762</eissn><isbn>9783805577403</isbn><isbn>3805577400</isbn><eisbn>9783318010787</eisbn><eisbn>3318010782</eisbn><abstract>Proliferation markers are widely used in general surgical pathology and also in pituitary pathology. They should help for differing aggressive or rapidly growing tumors from those with slower growth, as cellular atypia is not helpful for identifying aggressive adenomas of the pituitary. Only the number of mitoses is important for prognosis. A lot of markers can be used: antibodies for cyclins A, B, D and E, for proliferating cell nuclear antigen, Ki-67/Mib-1, antibodies for the inhibitory proteins p16, p27, p53, and for DNA topoisomerase IIalpha. A marker for apoptosis and its inhibitors may be also important. From our experiences, Mib-1 is the most reliable marker. The recommendation of this marker in the WHO classification of pituitary adenomas is fully justified.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>15281342</pmid><doi>10.1159/000079040</doi><oclcid>57235384</oclcid><tpages>17</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-3073 |
| ispartof | Frontiers of hormone research, 2004-01, Vol.32, p.110-126 |
| issn | 0301-3073 1662-3762 |
| language | eng |
| recordid | cdi_proquest_ebookcentralchapters_3016282_10_120 |
| source | Karger eBooks Collection Archiv (DFG Nationallizenzen); MEDLINE; Karger Book Series |
| subjects | Adenoma - metabolism Adenoma - pathology Biomarkers, Tumor - metabolism Cell Cycle Cell Division Chapter Humans Pituitary Neoplasms - metabolism Pituitary Neoplasms - pathology |
| title | Proliferation Markers and Cell Cycle Inhibitors in Pituitary Adenomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T04%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proliferation%20Markers%20and%20Cell%20Cycle%20Inhibitors%20in%20Pituitary%20Adenomas&rft.jtitle=Frontiers%20of%20hormone%20research&rft.au=Saeger,%20W.&rft.date=2004-01-01&rft.volume=32&rft.spage=110&rft.epage=126&rft.pages=110-126&rft.issn=0301-3073&rft.eissn=1662-3762&rft.isbn=9783805577403&rft.isbn_list=3805577400&rft_id=info:doi/10.1159/000079040&rft_dat=%3Cproquest_pubme%3EEBC3016282_10_120%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&rft.eisbn=9783318010787&rft.eisbn_list=3318010782&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=EBC3016282_10_120&rft_id=info:pmid/15281342&rfr_iscdi=true |